NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
NEOGEN CORP
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026
$11.63−0.18 (-1.52%)
Close on Oct 19, 2026
- Market cap
- $2.54B
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jul 30, 2021(first seen in filings) | 2-for-1 | Earlier per-share figures divided by 2 |
| Jun 7, 2021 | 2-for-1 | Earlier per-share figures divided by 2 |
| Dec 29, 2017 | 4-for-3 | Earlier per-share figures divided by 1.3333 |
| Oct 31, 2013 | 3-for-2 | Earlier per-share figures divided by 1.5 |
| Oct 31, 2013 | 3-for-2 | Earlier per-share figures divided by 1.5 |
| Dec 16, 2009 | 3-for-2 | Earlier per-share figures divided by 1.5 |
| Sep 5, 2007 | 3-for-2 | Earlier per-share figures divided by 1.5 |
| Jan 2, 2004 | 5-for-4 | Earlier per-share figures divided by 1.25 |